Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

Last Call for RESI SF Innovation Challenge Applications!

5 Dec

By Karen Deyo, Senior Investor Research Analyst, LSN

The deadline for applying to the RESI SF Innovation Challenge is tomorrow, Friday, Dec. 6th, and this is the last call for companies to submit their applications for consideration. The Innovation Challenge is a unique competition, where companies are selected using criteria such as innovativeness, stage of development, market size and opportunity and competitive landscape. The top companies, identified for their ‘investability,’ present posters in the exhibit hall on the day of the conference, competing for ‘investments’ of ‘RESI Cash’ from attendees to win prizes.

Participation in the Innovation Challenge can benefit finalists in many ways, including the increased exposure gained by the feature in the LSN Newsletter, the printed RESI Program Guide, as well as onsite signage at RESI. In addition, companies that actively seek ‘investments’ from attendees find that this can lead to many productive ad hoc meetings, furthering their fundraising campaigns in sometimes unexpected ways.

Click here to apply to the Innovation Challenge – good luck!

 

Artificial Intelligence is the Future of Healthcare

5 Dec

By Lucy Parkinson, VP of Investor Research, LSN

At LSN we speak to investors day in, day out, about what technologies they are seeking for their future portfolios. Many are now looking for artificial intelligence (AI) solutions across all of the sectors that LSN covers – drugs, devices, diagnostics and digital health. Investors are interested in the power of AI: from drug discovery tools to data analytics, from genomics to clinical decision support, and also including image analysis and patient monitoring, to name a few.

It’s clear that there is an emerging interest in bringing these fields together. LSN has already used RESI to dip our toes in the water of AI, with regular panels on AI in Healthcare; at RESI Taipei, Professor Jack Li delivered a presentation on the future AI landscape of healthcare, which highlighted the role AI can play in lowering the costs of future care delivery. We’ve found these topics have resonated with both investors and entrepreneurs in early stage life sciences. There are many avenues for adding AI as an extra dimension to new technologies, such as using AI to analyze data from new drugs or devices.

RESI San Francisco will include two investor panels specifically devoted to artificial intelligence: the broad AI in Healthcare panel, and a more focused panel on AI in Pathology and Imaging, a key sector for the advancement of healthcare AI.  AI is also a key topic in other panels such as Oncology Innovation and Investing in Life Science Tools.  With so much innovation happening in this space, RESI hopes to help investors and entrepreneurs who are focused on healthcare AI connect with each other.

LSN is planning further dedicated content in this space; look out for the launch of 4D Meets AI soon.

Global Family Office BioForum to Sponsor RESI’s 2020 Events Worldwide

5 Dec

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

We are delighted to announce that the Global Family Office Bioforum (GFOB) will be RESI’s title sponsor for 2020.

The Global Family Office BioForum (GFOB) is the leading alliance of international Family Offices focused on healthcare/life science which meets quarterly in 18 cities in the US, Europe and Asia.  GFOB also has a joint partnership with Life Science Nation and the RESI conference Series. These initiatives aim to assist the earliest stage life sciences companies by sourcing seed capital and management talent.

 

Life Science Nation’s, Focus on Cures Accelerator (FOC), Now Offering a Fundraising Campaign Curriculum

27 Nov

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

LSN recently launched the Focus on Cures (FOC) Accelerator that helps high-growth, international startup companies move into the global partnering arena through a two-week Boston-based immersion program, titled MKT 466: Funding and Partnering Immersion Course, integrated into LSN’s global partnering network and the RESI conference series. The theme of the FOC accelerator is to create a funnel of elite, top domestic and foreign startups that need to raise angel, seed, series A and B rounds. This course solves an early stage funding challenge: there is no standardized methodology for teaching a company how to brand and message itself and efficiently manage a fundraising campaign. There is no reliable, accurate, and current partner and investor database (besides LSN’s) to get a company a list of global partners that are a fit for their stage of development and product set. Very few entrepreneurs are actually taught how to launch and manage a fundraising campaign, never mind training CEOs how to make an introductory phone call or write an introductory email. Most importantly, no one teaches the holy grail of canvassing for capital, which is, how to follow up.

– Incubator
– Accelerator
– Government Agency
– Private Firm Seeking Funding

Participants in the course receive:

  • A year subscription to the LSN investor database, valued at $6,995
  • Branding and messaging collateral for fund raising campaign, (including a logo, tagline, one page data sheet, two page executive summary, and 10-12 slide pitch), valued at $15K
  • A ticket to the next RESI conference to launch the fundraising campaign, valued at $3,000

The course is $10,000 per company, for services valued at $25,000, held at the LSN corporate headquarters in Downtown Crossing, Boston. Each company is expected to send one business and one science executive for the two week immersion class. The first class will be held from May 25th through Jun 5th, leading up to RESI San Diego, taking place on Monday, June 8th.

FOC Accelerator – MKT 466 Funding and Partnering Immersion Course

MKT466 is a unique two-week immersion course designed for life science entrepreneurs to experience the best methodologies for reaching out and establishing a dialogue with partners and  investors, building a relationship and, ultimately, securing capital allocations.

The morning sessions are 3-hour classes teaching the fundamental business development and marketing skills needed to formulate a company theme, create a corporate brand with appropriate messaging and market your firm to investors and strategic partners within the life science arena. (See details in the morning class outline)

The afternoon sessions include 1 hour of meeting the players in the Massachusetts life science ecosystem and 2 hours of curating and reaching out to a list of global investors and channel partners:

  1. Utilize LSN’s Company Database to build a full picture of global landscape of competitors
  2. Utilize LSN’s Investor Database to find investors and partners that are a fit for your stage of development and product set and aggregate a global target list
  3. Refine investor-centric marketing collateral (following the instructions of the Branding and Messaging class)
  4. Leverage your infrastructure to do email marketing campaigns and nurture leads in a CRM
  5. Start email and phone canvassing each day, supervised and mentored by LSN expert BD staff
  6. Set up intro phone calls and meetings
  7. Prepare for the upcoming RESI conference

NEW! RESI Launches Featured Company Pitch Session

27 Nov

By Karen Deyo, Senior Investor Research Analyst, LSN

Are you looking to raise a private financing round or find a strategic partner for your life science startup?  The 27th Redefining Early Stage Investments (RESI) Partnering Conference is offering an opportunity to present your firm at our San Francisco event taking place on January 14th, 2020 event taking place at the Marines’ Memorial Club and Hotel near Union Square. We expect 500+ early stage investors to attend RESI San Francisco 2020, making this a unique opportunity to get your company’s message out.

Featured Pitch Sessions

Early Stage firms seeking licensing deals or Seed, Angel, Series A or B funding can secure a 15-minute presentation slot at the upcoming RESI Partnering Conference.  With RESI’s focused audience of life science investors, and a 1:1 ratio of investors to startups, presenting at RESI is a unique opportunity to get in front of early stage partners. RESI will host over 500 global early stage investors ranging from family offices and angels to strategic Pharma and MedTech players. Presenting at RESI gives companies an opportunity to build their profile.

If your firm is interested in presenting in the Early Stage Company Pitch Sessions please click below.  You will be required to submit a two-page executive summary and 10-12 page pitch deck with your application.

Deadline for applications December 12th 2019.

Fee structure

  • RESI registration fee per attendee (register here)
  • Presentation fee per company:  $1,500 

Who should present?

Any life science company that is developing products in the Drugs, Devices, Diagnostics or Digital Health arena and is seeking licensing or investment.

Presentation Details:

  • Early Stage companies are invited to request a 15-minute company presentation.
  • Presenting companies will be featured in the LSN Newsletter, RESI website and in the RESI conference program guide.

What about the RESI Innovation Challenge?

Those who are familiar with RESI know of the RESI Innovation Challenge, a competition for companies on the day of the conference, where they present posters in the exhibit hall and compete for ‘investments’ of ‘RESI Cash’ from attendees, with the most successful winning prizes at the end of the day. The RESI Innovation Challenge is unique in that it involves a rigorous merit-based selection process that assesses the ‘investability’ of a company based on the innovativeness of their technology, the stage of development and potential market size, to name a few of the many criteria. The Innovation Challenge has always been extremely selective, with many more applying than are accepted to participate. Participation in the Innovation Challenge for selected companies is at no extra cost, to ensure that the selective nature of the Innovation Challenge remains solely merit based (apply here). However, we have found that a large number of companies would like the opportunity to present their companies to the broad audience in attendance at RESI. To accommodate them, we are launching the RESI Featured Company Pitch Sessions.

RESI BACK TO EUROPE IN 2020! Save the Date!

27 Nov

By Gregory Mannix, Vice President International Business Development, LSN

RESI is returning to the Old Continent for the 2nd RESI Europe conference, this time to be held at the Hyatt Regency Etoile in Paris on March 23rd, 2020. Mark your calendar because you will not want to miss this unique gathering of 200+ global early stage life science investors.

NEW! RESI Launches Featured Company Pitch Session

21 Nov

By Gregory Mannix, Vice President International Business Development, LSN

Are you looking to raise a private financing round or find a strategic partner for your life science startup?  The 27th Redefining Early Stage Investments (RESI) Partnering Conference is offering an opportunity to present your firm at our San Francisco event taking place on January 14th, 2020 event taking place at the Marines’ Memorial Club and Hotel near Union Square. We expect 500+ early stage investors to attend RESI San Francisco 2020, making this a unique opportunity to get your company’s message out.

Featured Pitch Sessions

Early Stage firms seeking licensing deals or Seed, Angel, Series A or B funding can secure a 15-minute presentation slot at the upcoming RESI Partnering Conference.  With RESI’s focused audience of life science investors, and a 1:1 ratio of investors to startups, presenting at RESI is a unique opportunity to get in front of early stage partners. RESI will host over 500 global early stage investors ranging from family offices and angels to strategic Pharma and MedTech players. Presenting at RESI gives companies an opportunity to build their profile.

If your firm is interested in presenting in the Early Stage Company Pitch Sessions please click below.  You will be required to submit a two-page executive summary and 10-12 page pitch deck with your application.

Deadline for applications December 12th 2019.

Fee structure

  • RESI registration fee per attendee (register here)
  • Presentation fee per company:  $1,500 

Who should present?

Any life science company that is developing products in the Drugs, Devices, Diagnostics or Digital Health arena and is seeking licensing or investment.

Presentation Details:

  • Early Stage companies are invited to request a 15-minute company presentation.
  • Presenting companies will be featured in the LSN Newsletter, RESI website and in the RESI conference program guide.

What about the RESI Innovation Challenge?

Those who are familiar with RESI know of the RESI Innovation Challenge, a competition for companies on the day of the conference, where they present posters in the exhibit hall and compete for ‘investments’ of ‘RESI Cash’ from attendees, with the most successful winning prizes at the end of the day. The RESI Innovation Challenge is unique in that it involves a rigorous merit-based selection process that assesses the ‘investability’ of a company based on the innovativeness of their technology, the stage of development and potential market size, to name a few of the many criteria. The Innovation Challenge has always been extremely selective, with many more applying than are accepted to participate. Participation in the Innovation Challenge for selected companies is at no extra cost, to ensure that the selective nature of the Innovation Challenge remains solely merit based (apply here). However, we have found that a large number of companies would like the opportunity to present their companies to the broad audience in attendance at RESI. To accommodate them, we are launching the RESI Featured Company Pitch Sessions.

← Older Entries
Newer Entries →